These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4730980)

  • 21. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of tuberculosis patients with poor drug tolerance on the southern shore of the Crimea].
    Topchiev ShR; Dolgikh-Litt NA; Navrotski VV; Pertsovskii AI; Khmelevskaia GA
    Sov Med; 1972 Apr; 35(4):112-6. PubMed ID: 4662428
    [No Abstract]   [Full Text] [Related]  

  • 23. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
    Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
    Pandey R; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2005; 85(5-6):415-20. PubMed ID: 16256437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of treatment in patients with destructive pulmonary tuberculosis without consideration of drug sensitivity in Mycobacterium tuberculosis].
    Abashev IM; Kozlova AI; Ivanova LN
    Probl Tuberk Bolezn Legk; 2008; (1):33-5. PubMed ID: 18318228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of pyrazinamide on the liver in patients with tuberculosis. An ultrastructural study].
    Pilheu JA; de Salvo MC; Arias RF; Koch OR
    Medicina (B Aires); 1985; 45(1):15-9. PubMed ID: 3880102
    [No Abstract]   [Full Text] [Related]  

  • 29. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M; Tarantino AB; Mac Dowell A; Costa JA; Cunha JM; Pantoja W
    Rev Bras Med; 1967 Aug; 24(8):664-8. PubMed ID: 5603007
    [No Abstract]   [Full Text] [Related]  

  • 30. Pyrazinamide serum levels in childhood tuberculosis.
    Thee S; Detjen A; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1099-101. PubMed ID: 18713511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Functional state of the liver in patients with pulmonary tuberculosis during treatment with chemopreparations of the 2d series].
    Vasilik GV
    Probl Tuberk; 1968; 46(8):43-7. PubMed ID: 5709113
    [No Abstract]   [Full Text] [Related]  

  • 33. [Results of treatment with ethambutol and capreomycin in chronic pulmonary tuberculosis].
    Kozakow H; Potworowska M; Janowiec M; Klimkiewicz H; Niemirowski J; Pszonicka A; Pecyna-Sielewicz J; Polazek E; Rykowska Z; Frenkel A
    Gruzlica; 1969 Jul; 37(7):659-68. PubMed ID: 5350928
    [No Abstract]   [Full Text] [Related]  

  • 34. Relapse of tuberculosis in relation to previous treatment.
    Sellergren TL
    Scand J Respir Dis Suppl; 1970; 72():76-82. PubMed ID: 5273225
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute respiratory distress syndrome: a manifestation of immune reconstitution in an HIV-negative patient with tuberculosis].
    Wikman PE; Jover F; Peris J; Cuadrado JM
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):132-3. PubMed ID: 19254644
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ethambutol in combined chemotherapy of pulmonary tuberculosis].
    Kisielewicz J; Dobrzyński W; Fafrowicz B; Kociecka I; Szmygin J; Turczynowski R
    Gruzlica; 1970; 38(7):733-7. PubMed ID: 5453685
    [No Abstract]   [Full Text] [Related]  

  • 37. [Renal function in patients with minor forms of pulmonary tuberculosis in the course of treatment with 2d series drugs].
    Stepanenko VA
    Vrach Delo; 1972 Aug; 8():97-8. PubMed ID: 5073195
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical aspects and outcome of recurrent pulmonary tuberculosis].
    Krasnov VA; Potashova VA; Zyrianova TV; Naryshkina SL
    Probl Tuberk; 1993; (5):14-6. PubMed ID: 8295875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison between morphazinamide and pyrazinamide in retreatment of pulmonary tuberculosis].
    Zierski M
    Minerva Med; 1965 Sep; 56(71):2953-4. PubMed ID: 5322283
    [No Abstract]   [Full Text] [Related]  

  • 40. [Tolerance to antitubercular drugs in patients with tuberculosis complicated by peptic ulcer and gastric resection].
    Petrenko VM
    Klin Med (Mosk); 1978 Dec; 56(12):29-35. PubMed ID: 739743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.